Porous implant exposure: Incidence, management, and morbidity

Ophthalmic Plastic and Reconstructive Surgery

Volumn 23, Issue 1, 2007, Pages 1-7

  Custer, Philip L ^a   Trinkaus, Kathryn M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYAPATITE; POLYETHYLENE; POLYGLACTIN; ROSEOLIC ACID;

CONJUNCTIVA; DEVICE REMOVAL; ENUCLEATION; EVISCERATION; HEALING; HUMAN; IMPLANT; INCIDENCE; MORBIDITY; PERICARDIUM; PLASTIC SURGERY; POROSITY; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; SURGEON;

DURAPATITE; EYE ENUCLEATION; EYE EVISCERATION; HUMANS; INCIDENCE; ORBIT; ORBITAL IMPLANTS; POLYETHYLENE; POROSITY; RISK FACTORS; SURGICAL WOUND DEHISCENCE;

EID: 33846433127     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000249432.18688.ee     Document Type: Review

References (59)

1. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 1991;98:370-7.
2. Molteno AC, Elder MJ. Bone implants after enucleation. Aust N Z J Ophthalmol 1991;19:129-36.
3. Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol 1992; 113:669-73.
4. Nunery WR, Heinz GW, Bonnin JM, et al. Exposure rate of hydroxyapatite spheres in the anophthalmic socket: histopathologic correlation and comparison with silicone sphere implants. Ophthal Plast Reconstr Surg 1993;9:96-104.
5. Nunery WR, Cepela MA, Heinz GW, et al. Extrusion rate of silicone spherical anophthalmic socket implants. Ophthal Plast Reconstr Surg 1993;9:90-5.
6. Shields CL, Shields JA, De Potter P, Singh AD. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases. Trans Am Ophthalmol Soc 1993;91:177-89.
7. Karesh JW, Dresner SC. High-density porous polyethylene (Medpor) as a successful anophthalmic socket implant. Ophthalmology 1994;101:1688-95.
8. Leatherbarrow B, Kwartz J, Sunderland R, et al. The baseball orbital implant: a prospective study. Eye 1994;8:569-76.
9. Remulla HD, Rubin PAD, Shore JW, et al. Complications of porous spherical orbital implants. Ophthalmology 1995;102:586-93.
10. Fan JT, Robertson DM. Long-term follow-up of the Allen implant. Ophthalmology 1995;102:510-6.
11. McNab A. Hydroxyapatite orbital implants: experience with 100 cases. Aust N Z J Ophthalmol 1995;23:117-23.
12. Kostick DA, Lindberg JV. Evisceration with hydroxyapatite implant: surgical technique and review of 31 case reports. Ophthalmology 1995;102:1542-8.
13. Kaltreider SA, Newman SA. Prevention and management of complications associated with the hydroxyapatite implant. Ophthal Plast Reconstr Surg 1996;12:18-31.
14. Fong KS, Choo CT. Hydroxyapatite orbital implants: our local experience. Ann Acad Med Singapore 1997;26:405-8.
15. Jordan DR, Anderson RL. The universal implant for evisceration surgery. Ophthal Plast Reconstr Surg 1997;13:1-7.
16. Ashworth JL, Rhatigan M, Brammar R, et al. A clinical study of the hydroxyapatite orbital implant. Eur J Ophthalmol 1997;7:1-8.
17. Oestreicher JH, Liu E, Berkowitz M. Complications of hydroxyapatite orbital implants: a review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping. Ophthalmology 1997;104:324-9.
18. Yang JG, Khwarg SI, Wee WR, et al. Hydroxyapatite implantation with scleral quadrisection after evisceration. Ophthalmic Surg Lasers 1997;28:915-9.
19. Lee Sy, Kim HY, Kim SJ, Kang SJ. Human dura mater as a wrapping material for hydroxyapatite implantation in the anophthalmic socket. Ophthalmic Surg Lasers 1997;28:428-31.
20. Rubin PA, Rumelt PJ, Remulla H, et al. Enhancement of the cosmetic and functional outcome of enucleation with the conical orbital implant. Ophthalmology 1998;105:919-25.
21. Karcioglu ZA, Al-Mesfer SA, Mullaney PB. Porous polyethylene orbital implant in patients with retinoblastoma. Ophthalmology 1998;105:1311-6.
22. Christmas NJ, Gordon CD, Murray TG, et al. Intraorbital implants after enucleation and their complications: a 10-year review. Arch Ophthalmol 1998;116:1199-203.
23. Naugle TC, Lee AM, Haik BG, Callahan MA. Wrapping hydroxyapatite orbital implants with posterior auricular muscle complex grafts. Am J Ophthalmol 1999;128:495-501.
24. Stephen BE. The glass spherical hollow orbital implant: a prospective study. Ceylon Med J 1999;44:74-80.
25. Lee V, Subak-Sharpe I, Hungerford JL, et al. Exposure of primary orbital implants in postenucleation retinoblastoma patients. Ophthalmology 2000;107:940-5.
26. Long JA, Tann TM, Girkin CA. Evisceration: a new technique of trans-scleral implant placement. Ophthal Plast Reconstr Surg 2000;16:322-5.
27. Dresner SC, Karesh JW. Primary implant placement with evisceration in patients with endophthalmitis. Ophthalmology 2000;107: 1661-4.
28. Shah-Desai SD, Tyers AG, Manners RM. Painful blind eye: efficacy of enucleation and evisceration in resolving ocular pain. Br J Ophthalmol 2000;84:437-8.
29. Li T, Shen J, Duffy MT. Exposure rates of wrapped and unwrapped orbital implants following enucleation. Ophthal Plast Reconstr Surg 2001;17:431-5.
30. Char DH. Early wound dehiscence with use of hydroxyapatite orbital implant covered with calf pericardium. Br J Ophthalmol 2001;85:627-8.
31. Gayre GS, Debacker C, Lipham W, et al. Bovine pericardium as a wrapping for orbital implants. Ophthal Plast Reconstr Surg 2001;17:381-7.
32. 3). Ophthal Plast Reconstr Surg 2001;17:184-90.
33. Massry GG, Holds JB. Evisceration with scleral modification. Ophthal Plast Reconstr Surg 2001;17:42-7.
34. Inkster CF, Ng SGJ, Leatherbarrow B. Primary banked scleral patch graft in the prevention of exposure of hydroxyapatite orbital implants. Ophthalmology 2002;109:389-92.
35. Anderson RL, Yen MT, Lucci LM, Caruso RT. The quasi-integrated porous polyethylene orbital implant. Ophthal Plast Reconstr Surg 2002;18:50-5.
36. Suter AJ, Molteno CB, Bevin TH, et al. Long-term follow-up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol 2002;86:1287-92.
37. Perry JD, Goldberg RA, McCann JD, et al. Bovine hydroxyapatite orbital implant: a preliminary report. Ophthal Plast Reconstr Surg 2002;18:268-74.
38. Blaydon SM, Shepler TR, Heuhaus R, et al. The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthal Plast Reconstr Surg 2003;19:364-71.
39. Arat YO, Shetlar DJ, Boniuk M. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 2003;19:189-93.
40. Long JA, Tann TM, Bearden WH, Callahan MA. Enucleation: is wrapping the implant necessary for optimal motility? Ophthal Plast Reconstr Surg 2003;19:194-7.
41. Jordan DR, Gilberg S, Mawn LA. The Bioceramic orbital implant. Ophthal Plast Reconstr Surg 2003;19:128-35.
42. Nolan LM, O'Keefe M, Lanigan B. Hydroxyapatite orbital implant exposure in children. J AAPOS 2003;7:345-8.
43. Iordanidou V, De Potter P. Porous polyethylene orbital implant in the pediatric population. Am J Ophthalmol 2004;138:425-9.
44. Cheng MS, Liao SL, Lin LLK. Late porous polyethylene implant exposure after motility coupling post placement. Am J Ophthalmol 2004;138:420-4.
45. Jordan DR, Gilberg S, Bawazeer A. Coralline hydroxyapatite orbital implant (Bio-Eye): experience with 158 patients. Ophthal Plast Reconstr Surg 2004;20:69-74.
46. Perry JD, Tam RC. Safety of unwrapped spherical orbital implants. Ophthal Plast Reconstr Surg 2004;20:281-4.
47. Gupta M, Singh AD, Rundle PA, Rennie IG. Bovine pericardium (Ocu-Guard) wrap for hydroxyapatite implants. Br J Ophthalmol 2004;88:834-5.
48. Kim JH, Khwarg SI, Choung HK, Yu YS. Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation. Ophthalmic Surg Lasers Imaging 2004;35:446-52.
49. Chuah CT, Chee SP, Fong KS, et al. Integrated hydroxyapatite implant and non-integrated implants in enucleated Asian patients. Ann Acad Med Singapore 2004;33:477-83.
50. Christmas NJ, Van Quill K, Murray TG, et al. Evaluation of efficacy and complications: primary pediatric orbital implants after enucleation. Arch Ophthalmol 2000;118:503-6.
51. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5439 intraorbital implants and a review of the literature. Ophthal Plast Reconstr Surg 1995;11:77-88.
52. Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthal Plast Reconstr Surg 2004;20:274-80.
53. Jordan DR, Brownstein S, Faraji H. Clinicopathologic analysis of 15 explanted hydroxyapatite implants. Ophthal Plast Reconstr Surg 2004;20:285-90.
54. Pelletier CR, Jordan DR, Gilberg SM. Use of temporalis fascia for exposed hydroxyapatite orbital implants. Ophthal Plast Reconstr Surg 1998;14:109-203.
55. Massry GG, Holds JB. Frontal periosteum as an exposed orbital implant cover. Ophthal Plast Reconstr Surg 1999;15:79-82.
56. Lin CJ, Liao SL, Jou JR, et al. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br J Ophthalmol 2002;86:394-6.
57. Lee SY, Jang JW, Lew H, et al. Complications in motility peg placement for hydroxyapatite orbital implant in anophthalmic socket. Jpn J Ophthalmol 2002;46:103-7.
58. Jordan DR, Chan S, Mawn L, et al. Complications associated with pegging hydroxyapatite orbital implants. Ophthalmology 1999;106:505-12.
59. Edelstein C, Shields C, De Potter P, Shields J. Complications of motility peg placement for the hydroxyapatite orbital implant. Ophthalmology 1997;104:1616-21.